Clinical Trial Update: Phase 1 Study of Levocetirizine [Phase 1]

View source ↗

Summary

Phase 1 study of levocetirizine for dermatitis has completed, sponsored by GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatitis

Drugs mentioned

• Levocetirizine (Levocetirizine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dermatitis | Phase 1 | Status: COMPLETED